Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Five Prime Therapeutics Inc (NASDAQ:FPRX)

20.05
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
19.73
Today|||52-Week Range
53.89
-59.99%
Year-to-Date
No recent news for Five Prime Therapeutics Inc.

Today’s Trading

Previous close20.05
Today’s open21.00
Day’s range19.73 - 21.15
Volume2,499,533
Average volume (3 months)533,516
Market cap$604.3M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)-126.44%
Earnings growth (this year)-127.55%
Earnings growth (next 5 years)--
Revenue growth (last year)-91.92%
P/E ratioNM
Price/Sales44.01
Price/Book1.47

Competitors

 Today’s
change
Today’s
% change
RTRXRetrophin Inc0.000.00%
EDITEditas Medicine Inc0.000.00%
MYOVMyovant Sciences Ltd0.000.00%
EPZMEpizyme Inc0.000.00%
Data as of 4:02pm ET, 12/15/2017

Financials

Next reporting dateMarch 27, 2018
EPS forecast (this quarter)-$1.23
Annual revenue (last year)$30.7M
Annual profit (last year)-$65.7M
Net profit margin-214.06%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Lewis T. Williams
Chief Operating Officer &
Director
Aron M. Knickerbocker
Corporate headquarters
South San Francisco, California

Forecasts